HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 276, Issue 39, 36764-36769, September 28, 2001

This Article Abstract Full Text (PDF) All Versions of this Article: 276/39/36764    most recent M104578200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bai, L. Articles by Ghishan, F. K. Search for Related Content PubMed PubMed Citation Articles by Bai, L. Articles by Ghishan, F. K. Social Bookmarking                      What's this?

Molecular and Functional Analysis of a Novel Neuronal Vesicular Glutamate Transporter^*

Liqun Bai, Hua Xu, James F. Collins, and Fayez K. Ghishan^§

From the Departments of Pediatrics and Physiology, Steele Memorial Children's Research Center, University of Arizona Health Sciences Center, Tucson, Arizona 85724

Received for publication, May 18, 2001, and in revised form, June 26, 2001

	ABSTRACT

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Glutamate is the major excitatory neurotransmitter in the mammalian central nervous system. Packaging and storage of glutamate into glutamatergic neuronal vesicles requires ATP-dependent vesicular glutamate uptake systems, which utilize the electrochemical proton gradient as a driving force. VGLUT1, the first identified vesicular glutamate transporter, is only expressed in a subset of glutamatergic neurons. We report here the molecular cloning and functional characterization of a novel glutamate transporter, VGLUT2, from mouse brain. VGLUT2 has all major functional characteristics of a synaptic vesicle glutamate transporter, including ATP dependence, chloride stimulation, substrate specificity, and substrate affinity. It has 75 and 79% amino acid identity with human and rat VGLUT1, respectively. However, expression patterns of VGLUT2 in brain are different from that of VGLUT1. In addition, VGLUT2 activity is dependent on both membrane potential and pH gradient of the electrochemical proton gradient, whereas VGLUT1 is primarily dependent on only membrane potential. The presence of VGLUT2 in brain regions lacking VGLUT1 suggests that the two isoforms together play an important role in vesicular glutamate transport in glutamatergic neurons.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Neurotransmission depends on the regulated exocytotic release of vesicular transmitter molecules to the synaptic cleft, where they interact with postsynaptic receptors that subsequently transduce the information. Two types of neurotransmitter transporters have been identified based on membrane localization on plasma membrane or vesicular membrane. Removal of the transmitter from the synaptic cleft results in termination of the signal, and this requires destruction of transmitter or reuptake of transmitter back to the presynaptic terminal or glial cells via a sodium-dependent uptake system on the plasma membrane (1). Packaging and storage of neurotransmitters into specialized secretory vesicles in neurons ensures their regulated release. This storage is also crucial for protecting the neurotransmmitter molecules from leakage or intraneuronal metabolism and for protecting the neuron from possible toxic effects. This process is mediated by specific transporters on the vesicular membranes. At least four different types of vesicular transporters have been functionally identified that are specific for transport of classic neurotransmitters: monoamines, acetylcholine, -aminobutyric acid (GABA), and glutamate (2, 3). Unlike the plasma membrane transporters, which rely on a sodium gradient across the plasma membrane, all of these vesicular transport processes depend on the proton electrochemical gradient (µ_H+)¹ generated by a Mg²⁺-activated vacuolar H⁺-ATPase (V-ATPase) on the vesicular membrane (4). When protons are pumped into the vesicular lumen, a proton gradient (pH) and a membrane potential () occur across the membrane to form µ_H+, which favors the exchange of luminal protons for cytoplasmic transmitter. The transport of monoamines and acetylcholine rely predominantly on pH (5, 6), whereas the accumulation of GABA depends on both and pH (7, 8). In the case of glutamate, there is disagreement over whether the transport of glutamate is driven by only (9, 10, 11) or by both and pH components of µ_H+ (12, 13).

In addition to the differences in driving force, kinetic properties, substrate specificity, and ion dependence also clearly distinguish vesicular glutamate transport from high affinity plasma membrane glutamate transport. The vesicular ATP-dependent glutamate transporter is specific for glutamate, is stimulated by millimolar concentrations of chloride, and has a low affinity for uptake (K_m about 1-2 mM) (12, 14). These functional characteristics are in contrast to those of the plasma membrane glutamate transporter, which is sodium dependent, accepts aspartate as well as glutamate, and has a high affinity for glutamate with K_m in the 3-20 µM range (15, 16).

Although vesicular transporters for other neurotransmitters have been intensively studied at mechanistic, biochemical, and molecular levels, molecular cloning of vesicular glutamate transporters has only occurred recently. BNPI, a brain-specific sodium-dependent phosphate cotransporter originally characterized as a plasma membrane transporter, was recently localized on vesicular membranes of small synaptic vesicles in neurons (17, 18) and further functionally characterized as a vesicular glutamate transporter called VGLUT1 (18, 19). Uptake of glutamate by VGLUT1 has all of the functional characteristics previously reported for vesicular glutamate transporter with as the predominant driving force. However, only a subset of glutamatergic neurons expresses VGLUT1 (17, 20). Moreover, in Caenorhabditis elegans, loss-of-function mutations in the VGLUT1 orthologue eat-4, lead to impairment but not to a complete loss of glutamate-mediated neurotransmission (21, 22). These findings imply that an additional vesicular glutamate transporter(s) may exist. To identify new vesicular glutamate transporter isoforms, we searched the Genbank^TM Expressed Sequence Tags (EST) data base using human and rat VGLUT1 sequences (23, 24), and we found a mouse EST clone, which has ~49% homology with human and rat VGLUT1. We report here the molecular cloning and functional characterization of VGLUT2, the second identified vesicular glutamate transporter with different transport characteristics and cellular localization as compared with VGLUT1.

	EXPERIMENTAL PROCEDURES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Chemicals-- N,N'-dicyclohexylcarbodiimide (DCCD) was purchased from Fisher Scientific. All other chemicals were obtained from Sigma.

Isolation of cDNA Encoding Mouse VGLUT2-- The human and rat VGLUT1 sequences were used to search the GenBank^TM EST data base. One query gene (GenBank^TM number AI 841371) was identified from the mouse EST data base that has ~49% nucleotide identity with human and rat VGLUT1. This EST clone was obtained from Research Genetics (Huntsville, AL) and sequenced. The sequence was assembled and analyzed, and sequence comparisons were run using Omega software (version 1.1.3) and GenBank^TM BLAST searches. The full-length cDNA insert was excised with EcoRI and NotI and subcloned into the same sites of the pSPORT1 vector (Lifetech) and further subcloned into the pIRES2-EGFP vector (CLONTECH, Palo Alto, CA) at EcoRI and BamHI sites, resulting in VGLUT2-pIRES2-EGFP (the name VGLUT2 was given after the determination of transport characteristics).

Expression of VGLUT2 in PC12 Cells-- A rat pheochromocytoma cell line, PC12 cell (ATCC), which was used to characterize glutamate transport by VGLUT1 (19), was cultured in Dulbecco's modified Eagle's F-12 medium, supplemented with 20% fetal bovine serum, and 1% penicillin and streptomycin. VGLUT2-pIRES2-EGFP or pIRES2-EGFP without a cDNA insert (10 µg) was transfected into cells by the lipofection method (25). Transfected cells were selected with 800 µg/ml G418, and the most highly expressing cells were identified by fluorescence microscopy and selected for further analysis.

Preparation of Membrane Fractions from Transfected Cells and Glutamate Uptake-- Stably transfected cells were washed twice with ice-cold phosphate-buffered saline and homogenized in 0.32 M sucrose and 10 mM HEPES-KOH (pH 7.4) containing protease inhibitors. The resulting homogenate was pelleted at 1000 × g for 5 min to remove nuclei and at 27,000 × g for 35 min to remove heavier membranes. The supernatant containing lighter membranes, including synaptic-like microvesicles, was sedimented at 210,000 × g for 1 h, and the pellet was resuspended in 0.32 M sucrose, 4 mM MgSO₄, and 10 mM HEPES-KOH, pH 7.4 (uptake buffer) at a final concentration of 10 mg of protein/ml. Plasma membranes were prepared as previously described (26) and were also resuspended in uptake buffer at 10 mg protein/ml.

To start the transport assay, 100 µg of vesicular membrane or plasma membrane proteins in uptake buffer were mixed with 4 mM ATP, 4 mM KCl, and 50 µM L-[³H]glutamate (potassium salt, 0.4 Ci/mmol, Amersham Pharmacia Biotech) at room temperature for varying times, with other additions when indicated. Uptake was stopped by the addition of 4 × 2 ml of ice-cold 0.15 M KCl and immediate filtration. Radioactivity was determined with a liquid scintillation spectrophotometer.

Northern Blot Analysis-- A mouse, multiple-tissue Northern blot was purchased from Origene (Rockville, MD). Each lane was equally loaded with 2 µg of mRNA from different tissues. The blot was hybridized with [³²P]dCTP-labeled VGLUT2 cDNA-specific probes generated by polymerase chain reaction (nucleotides 2216-2489 from the 3'-untranslated region, which has low homology with VGLUT1). The filter was hybridized overnight at 42 °C in 50% formamide and washed under high stringency conditions (0.1× sodium chloride/sodium citrate, 0.1% SDS at 65 °C) for 1 h (27).

In Situ Hybridization of Mouse Brain-- In situ hybridization was performed as previously described (27), using paraffin-embedded mouse brain sections from Novagene (Madison, WI). The same polymerase chain reaction products used for Northern blots were subcloned in both orientations into the pCR II plasmid vector using the TA cloning kit (Invitrogen). cRNA probes were transcribed from these templates with T7 RNA polymerase using the MAXIscript in vitro transcription kit (Ambion, Austin, TX). Depending on the orientation of the insert, either sense (used as a negative control) or antisense (used as experimental) probes were generated. The cRNA transcripts were then labeled with biotin using the BrightStar Psoralen-Biotin labeling kit (Ambion). The biotinylated probes were hybridized to brain sections following the mRNAlocator-hyb kit protocol (Ambion). Briefly, mouse brain sections were rehydrated and predigested with 40 µg/ml of proteinase K for 30 min and then hybridized with 5 µg/ml of either antisense or sense cRNA probes at 55 °C for 4 h. Posthybridization washes were carried out at 55 °C three times for 4 min. The probes were detected using Ambion's mRNAlocator-biotin kit, and slides were photographed by standard light microscopy.

	RESULTS

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Molecular Cloning of Mouse VGLUT2-- We performed a search of the EST data base with the nucleotide sequence of human and rat VGLUT1 (BLASTx program). One mouse EST clone from amygdala exhibited significant similarity (~49%) with human and rat VGLUT1. By sequencing the clone from Research Genetics, we obtained a 2528 bp cDNA with an open reading frame of 1746 bp with 638 bp of 5'-untranslated sequence and 134 bp of 3'-untranslated sequence, which we named VGLUT2 (GenBank^TM accession number AF324864). The predicted protein has ~75-80% amino acid identity with human and rat VGLUT1 (Fig. 1 and data not shown). Particularly, VGLUT2 showed 97% amino acid identity to a recently cloned human differential sodium-dependent phosphate cotransporter, called DNPI (28). Hydropathy analysis suggests the presence of 8-10 membrane-spanning domains.

View larger version (93K): [in this window] [in a new window]   Fig. 1.   Comparison of amino acid sequences of mouse VGLUT2 and human VGLUT1. Identical sequences are shown in gray.

Functional Characteristics of VGLUT2-- We first determined the transport activity of different membranes from VGLUT2 or vector-only transfected cells. In the presence of 4 mM ATP, chloride and MgSO₄, conditions that optimize glutamate accumulation by native synaptic vesicles (12, 29), vesicle membranes from VGLUT2-IRES2-EGFP-transfected cells exhibited 5- to 6-fold increased uptake. Plasma membrane glutamate uptake from VGLUT2-IRES2-EGFP-transfected cells did not show any differences from that of IRES2-EGFP-transfected cells (Fig. 2A). The semiquantitative estimates of initial velocities of uptake were plotted in Fig. 2B. Kinetic experiments indicated that VGLUT2-mediated transport is dose-dependent and saturable (Fig. 2B). In one experiment depicted in Fig. 2B, the maximum velocity (V_max) was 1405 pmol/min-mg protein, and the apparent affinity constant (K_m) for glutamate was 1.2 mM. In three separate batches of membranes, the V_max was 1219 ± 109 pmol/min-mg protein, and the K_m for glutamate was 1.1 ± 0.2 mM. The K_m is similar to that of glutamate transport by native synaptic vesicles as well as VGLUT1 (1~2 mM), whereas it is in contrast to that of plasma glutamate transporters, which exhibit a K_m for glutamate between 3 and 20 µM (15, 16).

View larger version (29K): [in this window] [in a new window]   Fig. 2.   Functional characteristics of mouse VGLUT2. Glutamate uptake was performed in uptake buffer containing 4 mM ATP, 4 mM KCl, 4 mM MgSO4, and 50 µM L-[3H]glutamate (pH 7.4) unless specifically indicated below. All experiments were performed in triplicate with different membrane preparations. Error bars indicate S.D. A, time course of ATP-dependent glutamate uptake. VM, vesicular membranes; PM, plasma membranes; Vector, IRES2-EGFP vector only-transfected cells; VGLUT2, VGLUT2-IRES2-EGFP-transfected cells. B, the initial rate by VGLUT2 in vesicular membranes at 1.5 min in the presence of various concentrations of glutamate (50 µM to 50 mM). The uptake by vesicular membranes from vector only-transfected cells was subtracted as background. C, glutamate uptake was determined in the presence or absence of 4 mM various nucleotides or ATPase inhibitors for 5 min. Four mM ATP was used for ATPase inhibitor studies. Glutamate uptake by VGLUT2 is inhibited by bafilomycin A1 (Baf A1, 100 nM), DCCD (50 µM), and NEM (200 µM), but not by oligomycin B (5 µM), ouabain (2 mM), or vanadate (50 µM). *, p < 0.01. D, glutamate uptake was measured at various concentrations of chloride for 5 min. *, p < 0.01. E, substrate specificity of VGLUT2 was determined by competition of [3H]glutamate uptake with 10 mM unlabeled substrate for 5 min. One µM DIDS inhibits ~70% uptake. *, p < 0.01. F, glutamate uptake was measured at different pH values for 5 min.

In addition to kinetic properties, vesicular glutamate transport has a number of distinct characteristics from plasma membrane glutamate transport. Accumulation of glutamate into vesicular membranes depends on the vacuolar Mg²⁺-ATPase, which utilizes ATP, whereas plasma membrane glutamate transport depends on energy provided by the sodium gradient. VGLUT2-mediated glutamate transport is ATP-dependent, as substitution of ATP with ADP or AMP abolished glutamate transport (Fig. 2C). To specify the type of ATPase involved in glutamate uptake by VGLUT2, we tested inhibitors for different types of ATPases in transport assays. N-ethylmaleimide (NEM), DCCD, and bafalomycin A1, inhibitors for vacuolar Mg²⁺-ATPase dramatically inhibited glutamate uptake. The plasma membrane and mitochondrial ATPase inhibitors, vanadate, oligomycin B, and ouabain, had no effect on glutamate uptake by VGLUT2 (Fig. 2C), which is in agreement with previous work (10, 30).

Another feature of the vesicular glutamate transporter that segregates it from other neurotransmitter transporters is the marked stimulation seen in the presence of low, physiologically relevant concentrations of chloride (12, 13, 29, 30). At low concentrations (1-5 mM), chloride stimulates transport, whereas higher concentrations (above 10 mM) inhibit transport. Fig. 2D shows that low concentrations of chloride (1-4 mM) stimulated glutamate uptake by VGLUT2, whereas concentrations higher than 10 mM attenuated the stimulatory effect, which is consistent with previous findings.

Substrate specificity was also used to distinguish vesicular and plasma membrane glutamate transporters. Vesicular transporters recognize only glutamate, whereas plasma membrane transporters recognize both glutamate and aspartate. Uptake of [³H]glutamate by VGLUT2 was partially inhibited by D-glutamate, but not by a number of other compounds including aspartate, glycine, GABA, glutamine, and phosphate (Fig. 2E), which is consistent with known characteristics of glutamate transport by vesicular membranes. Evan blue, a potent inhibitor of vesicular glutamate transport, significantly blocked the uptake mediated by VGLUT2. In addition, 1 µM DIDS, an anion channel blocker, significantly inhibited VGLUT2-mediated glutamate uptake (Fig. 2E). Uptake by VGLUT2 is also pH-dependent, with the highest glutamate uptake occurring between pH 7.0 and 7.5 (Fig. 2F).

Components of the Electrochemical Proton Gradient Involved in VGLUT2-mediated Glutamate Transport-- To gain information about what component(s) of µ_H+ is involved in VGLUT2 transport, we determined the effect of ionophores on VGLUT2-mediated glutamate transport. The doses of ionophores were selected by testing the minimally effective doses in preliminary studies (data not shown). As shown in Fig. 3, carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone (FCCP), a protonophore acting as mobile carriers of H⁺-ions and dissipating both the and pH components of µ^H+, abolished glutamate uptake by VGLUT2. The K⁺ ionophore valinomycin, which reduces only without changing pH in the presence of 4 mM KCl, deceased glutamate uptake by VGLUT2. Nigericin is an electroneutral ionophore that exchanges K⁺ for H⁺, thus eliminating pH whereas allowing to increase when the H⁺-ATPase is working. Surprisingly, nigericin inhibited 40% of VGLUT2-mediated glutamate uptake in the presence of 4 mM KCl and subsaturating concentrations of glutamate. This observation is distinct from that of VGLUT1 in that nigericin increased VGLUT1-mediated glutamate uptake under the same conditions (19). But this is in agreement with previous results on synaptic vesicles (13, 31). Furthermore, the addition of both nigericin and valinomycin together essentially abolished glutamate uptake by VGLUT2.

View larger version (28K): [in this window] [in a new window]   Fig. 3.   Glutamate uptake by VGLUT2 in the presence of different ionophores. Vesicular membranes were preincubated for 5 min in the absence (control) or presence of ionophores (FCCP, 1 µM; nigericin, 1 µM; valinomycin, 20 µM). Uptake buffer is the same as described in the legend to Fig. 2. *, p < 0.01. Error bars are S.D.

Tissue and Cellular Distribution of VGLUT2 mRNA-- Mouse VGLUT2 expression was examined by probing poly(A)⁺ RNA from heart, brain, spleen, lung, liver, skeleton muscle, kidney, and testis. Northern blot analysis using mouse VGLUT2-specific probes detected a single transcript of ~3.8 kbp, with a strong hybridization signal observed only in brain (Fig. 4). In situ hybridization was then carried out to determine the regional and cellular expression of VGLUT2 mRNA in the mouse brain (Fig. 5). VGLUT2 is highly expressed in neuron-rich regions of the cerebral cortex (Fig. 5A), the hippocampus (Fig. 5B), and the hypothalamus (not shown). It is notable that VGLUT2 is highly expressed in neurons of the thalamus (Fig. 5, C and F), whereas VGLUT1 showed no or very low expression in the thalamus (20, 28). Very little if any specific signal was observed with sense probe (Fig. 5, G and H). Although the signal was present throughout layers II-VI of the cortex, VGLUT2 is more abundant in layers III to V, where a distinct signal is observed in pyramidal neurons (Fig. 5D). The hippocampus is very densely labeled compared with other brain regions. At higher magnification, VGLUT2 can be seen to be concentrated in pyramidal neurons of the hippocampus (Fig. 5E). Moreover, VGLUT2 mRNA is mainly localized to the cell bodies (Fig. 5, D, E, and F).

View larger version (86K): [in this window] [in a new window]   Fig. 4.   Northern blot analysis of mouse VGLUT2 mRNA expression in multiple tissues. Each lane contains 2 µg of poly(A+) RNA from the indicated tissues. A VGLUT2-specific probe was hybridized overnight at 42 °C in 50% formamide and washed under high stringency conditions.

View larger version (89K): [in this window] [in a new window]   Fig. 5.   In situ hybridization analysis of VGLUT2 expression in mouse brain. Mouse brain sections were hybridized with a biotin-labeled specific antisense (panels A-F) and sense (panels G and H: × 8) probes. Mouse VGLUT2 is highly expressed in the cerebral cortex (CTX) (panel A: × 8; panel D × 30), hippocampus (HP) (panel B: × 8; panel E: × 30), and thalamus (TH) (panel C: × 8; panel F: × 30).

	DISCUSSION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Glutamate is the major excitatory neurotransmitter in the mammalian central nervous system. It has been shown that glutamate can be accumulated into synaptic vesicles to concentrations of at least 60 mM through an ATP-dependent mechanism (32, 33). The vesicular transport system, in contrast to the sodium-dependent plasma membrane transport system, is specific for glutamate, has a low affinity for glutamate, and is stimulated by physiologically relevant concentrations of chloride (12, 13, 29, 30). These unique properties of the vesicular glutamate transporter are conserved in such diverse vertebrates as fish, reptiles, amphibians, and mammals (34). Consistent with these observations, glutamate was transported by VGLUT2 in the absence of sodium. Furthermore, the transport required ATP and was inhibited by specific inhibitors of the V-ATPase. Glutamate transported by VGLUT2 is saturable with a K_m of 1.1 mM, which is consistent with characteristics of the vesicular glutamate transporter. In addition, VGLUT2 is specific for glutamate and does not transport aspartate or other amino acids.

The requirement of low Cl concentrations is a significant property of vesicular glutamate transport. The presence of chloride at low concentrations (1-5 mM) is essential for the uptake of glutamate, with substantially lower transport activity observed at higher and lower levels (9, 13, 29). This biphasic effect of chloride and the DIDS-sensitive chloride dependence of glutamate uptake, have suggested that the vesicular glutamate transporter possesses an anion binding site, distinct from the substrate binding site, which regulates transporter activity (35). Chloride showed a similar effect on glutamate uptake by VGLUT2. We also observed a 70% inhibition in VGLUT2-mediated glutamate uptake by 1 µM DIDS, which is consistent with previous findings. Taken together, these functional characteristics suggest that VGLUT2 functions as a vesicular glutamate transporter.

Based on the high homology (97% at the amino acid level) between mouse VGLUT2 and human DNPI, we surmised that DNPI is the human homologue of mouse VGLUT2. By using Xenopus oocytes expressing hDNPI, Aihara et al. (28) observed an ~75% increase in sodium-dependent phosphate uptake. However, in our substrate specificity experiments, high concentrations of phosphate did not inhibit glutamate uptake by VGLUT2, suggesting that phosphate was not transported by the same mechanism as glutamate. This is a similar situation to VGLUT1, where weak sodium-dependent phosphate uptake was observed in oocyte plasma membranes expressing VGLUT1 (23, 24), and relatively strong ATP-dependent glutamate uptake was observed in vesicular membranes expressing VGLUT1 (18, 19). The relationship between glutamate and phosphate transport by VGLUT1 and VGLUT2 remains unclear. As has been proposed for VGLUT1 (19), VGLUT2 may be a bifunctional transporter, which functions as a phosphate transporter at the plasma membrane and a glutamate transporter in synaptic vesicles.

Whereas it is known that vesicular glutamate transport is driven by an electrochemical proton gradient generated by V-ATPase, the precise manner in which the glutamate transporter and V-ATPase operate is currently under debate. To assess the driving forces of glutamate transport mediated by VGLUT2, we tested the effect of different ionophores on VGLUT2-mediated glutamate uptake. In the presence of 4 mM KCl, the K⁺ ionophore valinomycin, which reduces only without changing pH, deceased glutamate uptake by VGLUT2 by 50%. Nigericin, an electroneutral ionophore that exchanges K⁺ for H⁺, eliminates pH whereas allowing to increase in the presence of 4 mM KCl and subsaturating concentrations of glutamate, inhibited glutamate uptake by VGLUT2 by 40%. This result is consistent with previous findings that both the and pH components are driving forces for the transport of glutamate into synaptic vesicles (13). However, this functional characteristic is distinct from VGLUT1, because was suggested as the primary driving force for VGLUT1 (18, 19). Thus, one possible explanation of the previous controversial results observed in synaptic vesicles could be the differing functions of two closely related isoforms. Further elucidation of molecular differences between these two isoforms may answer this question.

Another interesting finding is that the two vesicular glutamate transporters have different expression patterns in brain. VGLUT1 is only expressed in a subset of glutamatergic neurons in the cerebral cortex, hippocampus, and cerebellum (20), whereas VGLUT2 is expressed in cerebral cortex, hippocampus, and the thalamus (Fig. 5). Thalamic nuclei use glutamate as their neurotransmitter but they lack VGLUT1 mRNA and protein (17, 20). Thus, VGLUT2 appears to be an important glutamate transporter in thalamic neuronal vesicles. In addition, DNPI, the human homologue of VGLUT2, was highly expressed in the fetal brain when VGLUT1 was not expressed (28), suggesting that VGLUT2 rather than VGLUT1 might be important in the initial steps of neuronal differentiation.

In summary, we have cloned and functionally characterized a novel vesicular glutamate transporter expressed in the mouse brain. The VGLUT2 cDNA encodes a protein of 582 amino acids with 75% identity with human VGLUT1, the first identified vesicular glutamate transporter. All of the major functional characteristics of VGLUT2, such as ATP dependence, chloride stimulation, substrate specificity, substrate affinity, and mode of energization, are consistent with that of a glutamate transporter previously characterized from synaptic, vesicular membranes. Thus, VGLUT2 functions as a vesicular glutamate transporter. Identification of two isoforms with different functional characteristics provides molecular information for structure-function studies of vesicular glutamate transporters. In addition, the presence of VGLUT2 in brain regions lacking VGLUT1 suggests that the two isoforms together might account for glutamate transport into synaptic vesicles in glutamatergic neurons.

	ACKNOWLEDGEMENTS

We thank Dr. Naomi E. Rance (Department of Pathology, University of Arizona) and Dr. Bruce M. Coull (Department of Neurology, University of Arizona) for assistance with interpreting the in situ hybridization results.

	FOOTNOTES

^* This work was supported by NIDDK, National Institutes of Health Grant 2R01-R37DK-33209 and the W. M. Keck Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBank^TM/EMBL Data Bank with accession number(s) AF 324864.

Present address: Tucson Hospital Medical Education Program, 5301 E. Grant Rd., Tucson, AZ 85733. E-mail: lqbai@yahoo.com.

^§ To whom correspondence should be addressed: Dept. of Pediatrics, Director, Steele Memorial Children's Research Center, University of Arizona Health Sciences Center, 1501 N. Campbell Ave., Tucson, AZ 85724. Tel.: 520-626-5170; Fax: 520-626-4141; E-mail: fghishan@peds.arizona.edu.

Published, JBC Papers in Press, June 29, 2001, DOI 10.1074/jbc.M104578200

	ABBREVIATIONS

The abbreviations used are: µ_H+, proton electrochemical gradient; V-ATPase, vacuolar H⁺-ATPase; VGLUT1, vesicular glutamate transporter isoform 1; VGLUT2, vesicular glutamate transporter isoform 2; , membrane potential; pH, proton gradient; K_m, apparent affinity constant; V_max, maximal velocity; EST, expressed sequence tag; bp, base pair(s); DCCD, N,N'-dicyclohexylcarbodiimide; DIDS, 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid.

	REFERENCES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				L. A. Parra, T. Baust, S. El Mestikawy, M. Quiroz, B. Hoffman, J. M. Haflett, J. K. Yao, and G. E. Torres The Orphan Transporter Rxt1/NTT4 (SLC6A17) Functions as a Synaptic Vesicle Amino Acid Transporter Selective for Proline, Glycine, Leucine, and Alanine Mol. Pharmacol., December 1, 2008; 74(6): 1521 - 1532. [Abstract] [Full Text] [PDF]

				L.-E. Trudeau and R. Gutierrez On Cotransmission & Neurotransmitter Phenotype Plasticity Mol. Interv., June 1, 2007; 7(3): 138 - 146. [Abstract] [Full Text] [PDF]

				E. Hinoi, T. Takarada, K. Uno, M. Inoue, Y. Murafuji, and Y. Yoneda Glutamate Suppresses Osteoclastogenesis through the Cystine/Glutamate Antiporter Am. J. Pathol., April 1, 2007; 170(4): 1277 - 1290. [Abstract] [Full Text] [PDF]

				P. Newsholme, L. Brennan, and K. Bender Amino Acid Metabolism, {beta}-Cell Function, and Diabetes Diabetes, December 1, 2006; 55(Supplement_2): S39 - S47. [Abstract] [Full Text] [PDF]

				D. Moechars, M. C. Weston, S. Leo, Z. Callaerts-Vegh, I. Goris, G. Daneels, A. Buist, M. Cik, P. van der Spek, S. Kass, et al. Vesicular Glutamate Transporter VGLUT2 Expression Levels Control Quantal Size and Neuropathic Pain. J. Neurosci., November 15, 2006; 26(46): 12055 - 12066. [Abstract] [Full Text] [PDF]

				E. Hrabovszky, I. Kallo, G. F. Turi, K. May, G. Wittmann, C. Fekete, and Z. Liposits Expression of Vesicular Glutamate Transporter-2 in Gonadotrope and Thyrotrope Cells of the Rat Pituitary. Regulation by Estrogen and Thyroid Hormone Status Endocrinology, August 1, 2006; 147(8): 3818 - 3825. [Abstract] [Full Text] [PDF]

				J. Masson, M. Darmon, A. Conjard, N. Chuhma, N. Ropert, M. Thoby-Brisson, A. S. Foutz, S. Parrot, G. M. Miller, R. Jorisch, et al. Mice lacking brain/kidney phosphate-activated glutaminase have impaired glutamatergic synaptic transmission, altered breathing, disorganized goal-directed behavior and die shortly after birth. J. Neurosci., April 26, 2006; 26(17): 4660 - 4671. [Abstract] [Full Text] [PDF]

				S. Winter, I. Brunk, D. J. Walther, M. Holtje, M. Jiang, J.-U. Peter, S. Takamori, R. Jahn, L. Birnbaumer, and G. Ahnert-Hilger G{alpha}o2 Regulates Vesicular Glutamate Transporter Activity by Changing Its Chloride Dependence J. Neurosci., May 4, 2005; 25(18): 4672 - 4680. [Abstract] [Full Text] [PDF]

				E. Hrabovszky, G. Wittmann, G. F. Turi, Z. Liposits, and C. Fekete Hypophysiotropic Thyrotropin-Releasing Hormone and Corticotropin-Releasing Hormone Neurons of the Rat Contain Vesicular Glutamate Transporter-2 Endocrinology, January 1, 2005; 146(1): 341 - 347. [Abstract] [Full Text] [PDF]

				H. Hioki, F. Fujiyama, K. Nakamura, S.-X. Wu, W. Matsuda, and T. Kaneko Chemically Specific Circuit Composed of Vesicular Glutamate Transporter 3- and Preprotachykinin B-producing Interneurons in the Rat Neocortex Cereb Cortex, November 1, 2004; 14(11): 1266 - 1275. [Abstract] [Full Text] [PDF]

				V. Montana, Y. Ni, V. Sunjara, X. Hua, and V. Parpura Vesicular Glutamate Transporter-Dependent Glutamate Release from Astrocytes J. Neurosci., March 17, 2004; 24(11): 2633 - 2642. [Abstract] [Full Text] [PDF]

				Y. Moriyama and A. Yamamoto Glutamatergic Chemical Transmission: Look! Here, There, and Anywhere J. Biochem., February 1, 2004; 135(2): 155 - 163. [Abstract] [Full Text] [PDF]

				Z. Gerevich, S. J. Borvendeg, W. Schroder, H. Franke, K. Wirkner, W. Norenberg, S. Furst, C. Gillen, and P. Illes Inhibition of N-Type Voltage-Activated Calcium Channels in Rat Dorsal Root Ganglion Neurons by P2Y Receptors Is a Possible Mechanism of ADP-Induced Analgesia J. Neurosci., January 28, 2004; 24(4): 797 - 807. [Abstract] [Full Text] [PDF]

				D. N. Furness and D. M. Lawton Comparative Distribution of Glutamate Transporters and Receptors in Relation to Afferent Innervation Density in the Mammalian Cochlea J. Neurosci., December 10, 2003; 23(36): 11296 - 11304. [Abstract] [Full Text] [PDF]

				D. L. Rosin, B. D. Hettinger, A. Lee, and J. Linden Anatomy of adenosine A2A receptors in brain: Morphological substrates for integration of striatal function Neurology, December 9, 2003; 61(90116): S12 - 18. [Abstract] [Full Text]

				S. L. Petersen, E. N. Ottem, and C. D. Carpenter Direct and Indirect Regulation of Gonadotropin-Releasing Hormone Neurons by Estradiol Biol Reprod, December 1, 2003; 69(6): 1771 - 1778. [Abstract] [Full Text] [PDF]

				M. Hayashi, R. Morimoto, A. Yamamoto, and Y. Moriyama Expression and Localization of Vesicular Glutamate Transporters in Pancreatic Islets, Upper Gastrointestinal Tract, and Testis J. Histochem. Cytochem., October 1, 2003; 51(10): 1375 - 1390. [Abstract] [Full Text] [PDF]

				L. Bai, X. Zhang, and F. K. Ghishan Characterization of vesicular glutamate transporter in pancreatic alpha - and beta -cells and its regulation by glucose Am J Physiol Gastrointest Liver Physiol, May 1, 2003; 284(5): G808 - G814. [Abstract] [Full Text] [PDF]

				M. Hayashi, H. Yamada, S. Uehara, R. Morimoto, A. Muroyama, S. Yatsushiro, J. Takeda, A. Yamamoto, and Y. Moriyama Secretory Granule-mediated Co-secretion of L-Glutamate and Glucagon Triggers Glutamatergic Signal Transmission in Islets of Langerhans J. Biol. Chem., January 10, 2003; 278(3): 1966 - 1974. [Abstract] [Full Text] [PDF]

				R. T. Fremeau Jr., J. Burman, T. Qureshi, C. H. Tran, J. Proctor, J. Johnson, H. Zhang, D. Sulzer, D. R. Copenhagen, J. Storm-Mathisen, et al. The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate PNAS, October 29, 2002; 99(22): 14488 - 14493. [Abstract] [Full Text] [PDF]

				C. Gras, E. Herzog, G. C. Bellenchi, V. Bernard, P. Ravassard, M. Pohl, B. Gasnier, B. Giros, and S. El Mestikawy A Third Vesicular Glutamate Transporter Expressed by Cholinergic and Serotoninergic Neurons J. Neurosci., July 1, 2002; 22(13): 5442 - 5451. [Abstract] [Full Text] [PDF]

				P. G. Guyenet, C. P. Sevigny, M. C. Weston, and R. L. Stornetta Neurokinin-1 Receptor-Expressing Cells of the Ventral Respiratory Group Are Functionally Heterogeneous and Predominantly Glutamatergic J. Neurosci., May 1, 2002; 22(9): 3806 - 3816. [Abstract] [Full Text] [PDF]

				M. Hayashi, M. Otsuka, R. Morimoto, S. Hirota, S. Yatsushiro, J. Takeda, A. Yamamoto, and Y. Moriyama Differentiation-associated Na+-dependent Inorganic Phosphate Cotransporter (DNPI) Is a Vesicular Glutamate Transporter in Endocrine Glutamatergic Systems J. Biol. Chem., November 9, 2001; 276(46): 43400 - 43406. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 276/39/36764    most recent M104578200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bai, L. Articles by Ghishan, F. K. Search for Related Content PubMed PubMed Citation Articles by Bai, L. Articles by Ghishan, F. K. Social Bookmarking                      What's this?